MedTrace Logo

Acute Kidney Injury and Acute Kidney Disease in COVID-19

NCT04353583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2025-03-06

No results posted yet for this study

Summary

Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagnosed with COVID-19.

Conditions

Sponsors & Collaborators

  • University of Giessen

    lead OTHER

Principal Investigators

  • Werner Seeger, MD · University Hospital Giessen and Marburg, Giessen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-21
Primary Completion
2022-05-17
Completion
2025-02-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04353583 on ClinicalTrials.gov